The pathophysiology of infection and PASC is complex and multifactorial, involving direct organ damage from virus infection ..
2) ...immune system dysregulation, autoimmune responses, microthrombosis, and persistent viral proteins/inflammation.
Multiple functions and organs are commonly impacted include lungs (pulmonary fibrosis, vascular dysfunction), heart (myocarditis, microvascular damage),
3) ...brain (neuroinflammation, autonomic dysfunction), gut (microbiome changes), kidneys, blood (hypercoagulability), and skin.
In these tables, there are the systems affected, the number of patients, their characteristics, symptoms and so many reference studies.
4) We have decided in this thread to summarize partially, these 2 tables with affected systems, nb of studies, nb of patients and symptoms, to visualise to what extent COVID-19 can impact our body.
5) ๐๐๐๐๐๐๐ผ๐๐๐๐ ๐๐๐๐๐๐
12 studies, more than 3.000 patients, follow-up 3-12 months, symptoms :
โถ๏ธ 42% of survivors had mild pulmonary function abnormalities
โถ๏ธ 25.4% of the patients, mostly demonstrated diffusion reductions in DLCO
...
6)
โถ๏ธ Diminished TLC and diffusion capacity in 23 and 36 participants
โถ๏ธ Impaired DLCO in 33 (36%) and VA in 24 (26%) participants
โถ๏ธ Abnormal pulmonary function in 43 (75.4%) patients
โถ๏ธ Pulmonary diffusion abnormality in 22-56% of participants
...
9) ๐๐๐๐๐๐๐ ๐๐๐๐๐๐ ๐๐ฃ๐ ๐๐๐๐พ๐๐๐ผ๐๐๐๐พ ๐ฟ๐๐๐๐๐ฟ๐๐๐
8 studies, more than 100.000 patients, follow-up 15 days-6 months, symptoms :
โถ๏ธ Smell and taste loss was reported in 68% (40/59)
โถ๏ธ Fatigue (40), "brain fog" (29), and changes in cognition (25)
10) โถ๏ธ Headache (97, 74.6%), severe headache (24), anosmia/ageusia (54.6% vs. 18.2% in headache)
โถ๏ธ Late onset of Guillain-Barrรฉ syndrome
โถ๏ธ 28% PTSD, 31% depression, 42% anxiety, 20% OC symptoms, and 40% insomnia
โถ๏ธ Psychiatric illness (18.1%), mood disorder (9.9%)
...
11) There is of course much more information in this fascinating study that we highly recommend.
2) SARS-CoV-2 has undergone two major evolutionary jumps - from pre-Omicron variants to Omicron BA.1, and from XBB variants to BA.2.86/JN.1. These resulted in increased genetic divergence.
3) Variants like BA.1, XBB.1.5, BQ.1.1, and JN.1 displayed high relative growth advantages (116%, 80%, 71%, 93% respectively) allowing them to outcompete other co-circulating variants.
2) The study investigated the persistence of SARS-CoV-2 in tissues of patients who had recovered from mild COVID-19. Samples were collected from various tissues at 1 month, 2 months, and 4 months post-infection.
3) Viral RNA was detected in tissues like the liver, kidney, stomach, intestine, brain, blood vessels, lung, breast, skin, and thyroid across the timepoints, with detection rates gradually decreasing over time.
2) The study aimed to understand how repeated vaccination with the ancestral SARS-CoV-2 mRNA vaccine induces antibodies that can neutralize Omicron variants, which have mutations that allow immune escape.
3) They analyzed blood samples from 41 individuals who received three doses of the BNT162b2 mRNA vaccine. Samples were collected at various time points to track the immune response.
2) The study develops a mathematical model to examine the impact of individual avoidance behavior and policy-mediated behavior change on SARS-CoV-2 transmission during the second wave in Ontario, Canada from September 2020 to February 2021.
3) A parameter describing individual avoidance behavior in response to increasing cases is estimated based on survey data collected during this period. The model stratifies the population by age and risk-taking levels.
2) The study investigated the fluctuating nature and trajectory of post-COVID pain in previously hospitalized COVID-19 survivors over 18 months using Sankey plots and exponential bar plots.
3) The prevalence of post-COVID pain was 41.07% at 6 months, 34.29% at 12 months, and 28.47% at 18 months. Sankey plots showed a fluctuating pattern, with some patients developing delayed-onset pain.
2) Endogenous retroviruses (ERVS) are genetic elements that are derived from ancient retroviral infections and are integrated into the genome of a host organism. Retroviruses are a type of RNA virus that has the ability to convert their RNA genome into DNA and ...
3) ... integrate it into the host cell's genome. When retroviruses infect germ cells (sperm or egg cells), the viral DNA can be passed on to subsequent generations.